Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers*
- 1 November 2005
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 11 (6) , 350-359
- https://doi.org/10.1111/j.1601-0825.2005.01127.x
Abstract
Oral squamous cell carcinoma (OSCC) is the sixth most common malignancy and is a major cause of cancer morbidity and mortality worldwide. Carcinoma of the uterine cervix is the most common female malignancy in the world. While cervical cancer is a worldwide disease, oral cancer has the highest incidence in developing countries, especially among tobacco and alcohol users and betel quid chewers. A strong association of cervical and oral cancer with high-risk human papillomavirus (HPV) 16 and 18 infections underlines the importance of the virus in the pathogenesis of these squamous cell carcinomas. Functionally high-risk HPV infection contributes to carcinogenesis and tumor progression predominantly through the actions of two viral oncogenes, E6 and E7. The E6 and E7 genes have been studied in different patient populations and a number of variants have been described. More than 40 variants have been classified and may be related to differences in progression of squamous intraepithelial lesions. The transcription factor, NFkappaB and its activation pathways are frequently targeted by viruses and aberrant constitutive activation of NFkappaB is frequently found in human tumors of diverse tissue origin. Diet-gene interactions are also likely to contribute considerably to the observed inter-individual variations in HPV associated cancer risk, in response to exposures to the nutritional factors that have the potential to promote or protect against cancer.Keywords
This publication has 102 references indexed in Scilit:
- Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South IndiaZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical diseaseBritish Journal of Cancer, 2002
- CYP1A1, GSTM1, and GSTT1 Polymorphisms and the Risk of Cervical Squamous Intraepithelial Lesions in a Multiethnic PopulationGynecologic Oncology, 2001
- Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-κB-Responsive Genes in Cervical KeratinocytesJournal of Virology, 2001
- Genetic variability in susceptibility and response to toxicantsToxicology Letters, 2001
- Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1a1, and CYP2e1Cancer, 2000
- Cancer genes: single and susceptibility: exposing the differencePharmacogenetics, 1995
- Correlation of Cervical Cancer Mortality with Reproductive and Dietary Factors, and Serum Markers in ChinaInternational Journal of Epidemiology, 1994
- Pharmacogenetic Phenotyping and GenotypingClinical Pharmacokinetics, 1994